Výsledky vyhledávání - Jenna D. Goldberg

Upřesnit hledání
  1. 1
    Clinical applications of palifermin: amelioration of oral mucositis and other potential indications

    Clinical applications of palifermin: amelioration of oral mucositis and other potential indications Autor Saroj Vadhan‐Raj, Jenna D. Goldberg, Miguel‐Angel Perales, Dietmar Berger, Marcel R.M. van den Brink

    Vydáno 2013
    Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  2. 2
    S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY

    S194: TECLISTAMAB (TEC) + NIROGACESTAT (NIRO) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): THE PHASE 1B MAJESTEC-2 STUDY Autor Fritz Offner, O. Decaux, Cyrille Hulin, Sébastien Anguille, Anne Sophie Michallet, Luciano J. Costa, Cyrille Touzeau, Kevin Boyd, Deeksha Vishwamitra, Yue Guo, Zhuolu Niu, Julie S. Larsen, Lingling Chen, Arnob Banerjee, Jenna D. Goldberg, Jeffrey Matous

    Vydáno 2023
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma

    Effects of teclistamab and talquetamab on soluble BCMA levels in patients with relapsed/refractory multiple myeloma Autor Suzette Girgis, Shun Xin Wang Lin, Kodandaram Pillarisetti, Raluca Verona, Diego Vieyra, Tineke Casneuf, Damien Fink, Xin Miao, Yang Chen, Tara Stephenson, Arnob Banerjee, Brandi Hilder, Jeffery S. Russell, Jeffrey R. Infante, Yusri Elsayed, Jennifer Smit, Jenna D. Goldberg

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

    A Phase 1, First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) x CD3 Bispecific Antibody, in Patients with Relapsed and/or Refracto... Autor Ajai Chari, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez, Elham Askari, María‐Victoria Mateos, Monique C. Minnema, Raluca Verona, Suzette Girgis, Thomas J. Prior, Brandi Hilder, Jeffery S. Russell, Jenna D. Goldberg, Amrita Krishnan

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  5. 5
    A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit Cord Blood Transplantation

    A Novel Reduced-Intensity Conditioning Regimen Induces a High Incidence of Sustained Donor-Derived Neutrophil and Platelet Engraftment after Double-Unit Cord Blood Transplantation Autor Doris M. Ponce, Craig S. Sauter, Sean M. Devlin, Marissa Lubin, Anne Marie Gonzales, Nancy A. Kernan, Andromachi Scaradavou, Sergio Giralt, Jenna D. Goldberg, Guenther Koehne, Miguel‐Angel Perales, James W. Young, Hugo Castro‐Malaspina, Ann A. Jakubowski, Esperanza B. Papadopoulos, Juliet N. Barker

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease

    Assessment of Joint and Fascia Manifestations in Chronic Graft‐Versus‐Host Disease Autor Yoshihiro Inamoto, Joseph Pidala, Xiaoyu Chai, Brenda F. Kurland, Daniel Weisdorf, Mary E.D. Flowers, Jeanne Palmer, Sally Arai, David A. Jacobsohn, Corey Cutler, Madan Jagasia, Jenna D. Goldberg, Paul J. Martin, Steven Z. Pavletic, Georgia B. Vogelsang, Stephanie J. Lee, Paul A. Carpenter

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse

    CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Hos... Autor Roni Tamari, Stephen S. Chung, Esperanza B. Papadopoulos, Ann A. Jakubowski, Patrick Hilden, Sean M. Devlin, Jenna D. Goldberg, Miguel‐Angel Perales, Doris M. Ponce, Craig S. Sauter, Molly Maloy, Dara Herman, Virginia M. Klimek, James W. Young, Richard J. O’Reilly, Sergio Giralt, Hugo Castro‐Malaspina

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma

    Updated Phase 1 Results from MonumenTAL-1: First-in-Human Study of Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with R... Autor Amrita Krishnan, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Elham Askari, María‐Victoria Mateos, Luciano J. Costa, Raluca Verona, Xuewen Ma, Suzette Girgis, Shiyi Yang, Brandi Hilder, Jeffery S. Russell, Jenna D. Goldberg, Ajai Chari

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study

    Teclistamab in Combination with Subcutaneous Daratumumab and Lenalidomide in Patients with Multiple Myeloma: Results from One Cohort of MajesTEC-2, a Phase1b, Multicohort Study Autor Emma Searle, Hang Quach, Sandy W. Wong, Luciano J. Costa, Cyrille Hulin, Wojt Janowski, Jesús G. Berdeja, Sébastien Anguille, Jeffrey Matous, Cyrille Touzeau, Anne‐Sophie Michallet, Marla Husnik, Deeksha Vishwamitra, Zhuolu Niu, Julie S. Larsen, Ling‐Ling Chen, Jenna D. Goldberg, Rakesh Popat, Andrew Spencer

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

    Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant Autor Jenna D. Goldberg, Junting Zheng, Ravin Ratan, Trudy N. Small, Kuan-Chi Lai, Farid Boulad, Hugo Castro‐Malaspina, Sergio Giralt, Ann A. Jakubowski, Nancy A. Kernan, Richard J. O’Reilly, Esperanza B. Papadopoulos, James W. Young, Marcel R.M. van den Brink, Glenn Heller, Miguel‐Angel Perales

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM)

    Updated Phase 1 Results of Teclistamab, a B-Cell Maturation Antigen (BCMA) x CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM) Autor Alfred L. Garfall, Saad Z. Usmani, María‐Victoria Mateos, Hareth Nahi, Niels W.C.J. van de Donk, Jesús F. San Miguel, Albert Oriol Rocafiguera, Laura Rosiñol, Ajai Chari, Manisha Bhutani, Lixia Pei, Raluca Verona, Suzette Girgis, Tara Stephenson, Jenna D. Goldberg, Arnob Banerjee, Amrita Krishnan

    Vydáno 2020
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

    Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma Autor Ajai Chari, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Elham Askari, María‐Victoria Mateos, Luciano J. Costa, Jo Caers, Raluca Verona, Suzette Girgis, Shiyi Yang, Rachel B. Goldsmith, Xiang Yao, Kodandaram Pillarisetti, Brandi Hilder, Jeffery S. Russell, Jenna D. Goldberg, Amrita Krishnan

    Vydáno 2022
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation

    High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation Autor Doris M. Ponce, Patrick Hilden, Christen L. Mumaw, Sean M. Devlin, Marissa Lubin, Sergio Giralt, Jenna D. Goldberg, Alan M. Hanash, Katharine C. Hsu, Robert R. Jenq, Miguel‐Angel Perales, Craig S. Sauter, Marcel R.M. van den Brink, James W. Young, Renier J. Brentjens, Nancy A. Kernan, Susan E. Prockop, Richard J. O’Reilly, Andromachi Scaradavou, Sophie Paczesny, Juliet N. Barker

    Vydáno 2014
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1

    Population Pharmacokinetics and Exposure–Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1 Autor Xin Miao, Liviawati S. Wu, Shun Xin Wang Lin, Yan Xu, Yang Chen, Yuki Iwaki, Rachel Kobos, Tara Stephenson, Kristy Kemmerer, Clarissa Uhlar, Arnob Banerjee, Jenna D. Goldberg, Danielle Trancucci, Amit Apte, Raluca Verona, Lixia Pei, Rachit Desai, Kathleen T. Hickey, Yaming Su, Danièle Ouellet, Mahesh N. Samtani, Yue Guo, Alfred L. Garfall, Amrita Krishnan, Saad Z. Usmani, Honghui Zhou, Suzette Girgis

    Vydáno 2023
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study

    Correlation of immune fitness with response to teclistamab in relapsed/refractory multiple myeloma in the MajesTEC-1 study Autor Diana Cortés‐Selva, Tatiana Perova, Sheri Skerget, Deeksha Vishwamitra, Sarah Stein, Rengasamy Boominathan, On Say Lau, Karl C. Nielsen, Cuc Davis, Jaymala Patel, Arnob Banerjee, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Jenna D. Goldberg, Lixia Pei, Danielle Trancucci, Suzette Girgis, Shun Xin Wang Lin, Liviawati S. Wu, Philippe Moreau, Saad Z. Usmani, Nizar J. Bahlis, Niels W.C.J. van de Donk, Raluca Verona

    Vydáno 2024
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease

    Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease Autor Robert R. Jenq, Ying Taur, Sean M. Devlin, Doris M. Ponce, Jenna D. Goldberg, Katya Ahr, Eric R. Littmann, Lilan Ling, Asia Gobourne, Liza Miller, Melissa D. Docampo, Jonathan U. Peled, Nicholas Arpaia, Justin R. Cross, Tatanisha Peets, Melissa Lumish, Yusuke Shono, Jarrod A. Dudakov, Hendrik Poeck, Alan M. Hanash, Juliet N. Barker, Miguel‐Angel Perales, Sergio Giralt, Eric G. Pamer, Marcel R.M. van den Brink

    Vydáno 2015
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from MonumenTAL-1

    Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 Results from... Autor Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels WCJ van de Donk, Paula Rodríguez‐Otero, Elham Askari, María‐Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Krishnan, Deeksha Vishwamitra, Xuewen Ma, Xiang Qin, Katharine S. Gries, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Christoph Heuck, Jesús F. San Miguel, Philippe Moreau

    Vydáno 2022
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response

    Ex Vivo CD34+–Selected T Cell–Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is As... Autor Pere Barba, Patrick Hilden, Sean M. Devlin, Molly Maloy, Djamilia Dierov, Jimmy Nieves, Matthew D. Garrett, Julie Sogani, Christina Cho, Juliet N. Barker, Nancy A. Kernan, Hugo Castro‐Malaspina, Ann A. Jakubowski, Guenther Koehne, Esperanza B. Papadopoulos, Susan E. Prockop, Craig S. Sauter, Roni Tamari, Marcel R.M. van den Brink, Scott T. Avecilla, Richard Meagher, Richard J. O’Reilly, Jenna D. Goldberg, James W. Young, Sergio Giralt, Miguel‐Angel Perales, Doris M. Ponce

    Vydáno 2016
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma

    Updated Results from MajesTEC-1: Phase 1/2 Study of Teclistamab, a B-Cell Maturation Antigen x CD3 Bispecific Antibody, in Relapsed/Refractory Multiple Myeloma Autor Philippe Moreau, Saad Z. Usmani, Alfred L. Garfall, Niels W.C.J. van de Donk, Hareth Nahi, Jesús F. San Miguel, Albert Oriol, Ajay K. Nooka, Thomas G. Martin, Laura Rosiñol, Ajai Chari, Lionel Karlin, Lotfi Benboubker, María‐Victoria Mateos, Nizar J. Bahlis, Rakesh Popat, Britta Besemer, Joaquín Martínez‐López, Surbhi Sidana, Lixia Pei, Danielle Trancucci, Raluca Verona, Suzette Girgis, Yunsi Olyslager, Mindy Jaffe, Clarissa Uhlar, Tara Stephenson, Rian Van Rampelbergh, Arnob Banerjee, Jenna D. Goldberg, Rachel Kobos, Amrita Krishnan

    Vydáno 2021
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study

    Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 study Autor Ajai Chari, Cyrille Touzeau, Carolina Schinke, Monique C. Minnema, Jesús G. Berdeja, Albert Oriol, Niels W.C.J. van de Donk, Paula Rodríguez‐Otero, Daniel Morillo, Carmen Martínez‐Chamorro, María-Victoria Mateos, Luciano J. Costa, Jo Caers, Leo Rasche, Amrita Krishnan, Jing Christine Ye, Lionel Karlin, Brea Lipe, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen Ma, Xiang Qin, Hein Ludlage, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna D. Goldberg, Colleen Kane, Christoph Heuck, Jesús F. San Miguel, Philippe Moreau

    Vydáno 2025
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: